A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent...

Area of Science:

• Pharmaceutical Sciences
• Drug Stability
• Degradation Kinetics

Background:

• A novel cardiovascular drug candidate requires comprehensive stability assessment.
• Understanding degradation pathways is crucial for formulation development and shelf-life prediction.

Purpose of the Study:

• To elucidate the degradation mechanisms of a cardiovascular drug candidate.
• To evaluate the impact of various conditions (pH, light, oxygen, excipients) on drug stability.
• To identify degradation products and propose degradation pathways.

Main Methods:

• Forced degradation studies in solution and solid-state under various stress conditions (temperature, humidity, light).
• Analysis of degradation kinetics as a function of pH, concentration, and presence of ethylenediaminetetraacetic acid (EDTA).
• Identification of degradation products using mass spectrometry and determination of critical micelle/aggregation concentration (CMC/CAC).

Main Results:

• Degradation was significantly reduced by adding EDTA and eliminated under anaerobic conditions.
• The drug exhibited stability between pH 3 and 7, but degraded rapidly under ambient light.
• Photodegradation was concentration-dependent, with aggregation above CMC/CAC protecting the active pharmaceutical ingredient (API).
• Amorphous forms degraded faster than crystalline forms, with no significant difference between neutral and salt forms.

Conclusions:

• Drug stability can be enhanced by controlling oxygen exposure and utilizing EDTA.
• The compound's aggregation behavior plays a protective role against photodegradation in solution.
• Formulation strategies should consider pH, light protection, and concentration relative to CMC/CAC for optimal stability.